PTGS2 and cancer: Additionally, the 1,25(OH)2D/VDR signalling axis plays a pivotal role in modulating the inflammatory pathways associated with cancer by downregulating cyclooxygenase-2 (COX-2), prostaglandin synthesis, and NF-kB signalling.